EA200700672A1 - METHOD OF OBTAINING THE ACID-MILK PRODUCT AND METHOD OF CORRECTING MICROFLORA IN THE ORGANISM - Google Patents
METHOD OF OBTAINING THE ACID-MILK PRODUCT AND METHOD OF CORRECTING MICROFLORA IN THE ORGANISMInfo
- Publication number
- EA200700672A1 EA200700672A1 EA200700672A EA200700672A EA200700672A1 EA 200700672 A1 EA200700672 A1 EA 200700672A1 EA 200700672 A EA200700672 A EA 200700672A EA 200700672 A EA200700672 A EA 200700672A EA 200700672 A1 EA200700672 A1 EA 200700672A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- sour
- milk product
- microflora
- milk
- animals
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Изобретение относится к области микробиологии, в частности к способам получения кисло-молочных продуктов и к способам коррекции микрофлоры в организме человека и животных с помощью кисло-молочных продуктов. Способ получения кисло-молочного продукта включает смешивание обезжиренного или цельного молока с яичным меланжем, стерилизацию полученной смеси, охлаждение, внесение в охлажденную смесь штамма Lactobacillus acidophilus - АГ/17-666 и выдерживание в термостате. Способ коррекции микрофлоры в организме человека и животных включает введение кисло-молочного продукта, полученного из штамма Lactobacillus acidophilus - АГ/17-666, при этом животным кисло-молочный продукт вводят из расчета на 1 кг веса или на количество голов - от 0,01 до 500,0 мл в зависимости от места введения, вида и возраста животного, а человеку - от 1,0 до 200,0 мл в зависимости от места введения и возраста. Кисло-молочный продукт вводят человеку и животным для коррекции микрофлоры: желудочно-кишечного тракта, матки и влагалища, ротовой, конъюнктивальной и носовой полостей, раневых полостей различной этиологии. Заявленные способы обеспечивают увеличение сроков хранения кисло-молочного продукта и улучшение вкусовых свойств за счет снижения кислотности среды, которая находится в пределах 70-200°Т; снижение кислотности среды также обеспечивает повышение эффективности при использовании кисло-молочного продукта для коррекции микрофлоры, т.к. создает благоприятную среду для лактобактерий.The invention relates to the field of microbiology, in particular, to methods for producing sour-milk products and to methods for correcting microflora in humans and animals by using sour-milk products. The method of obtaining a sour-milk product includes mixing skimmed or whole milk with egg melange, sterilizing the resulting mixture, cooling, adding Lactobacillus acidophilus - AH / 17-666 to the cooled mixture and keeping it in a thermostat. The method of correcting microflora in humans and animals includes the introduction of a sour-milk product obtained from the strain Lactobacillus acidophilus - AH / 17-666, while the sour-milk product is administered to animals at the rate of 1 kg of weight or the number of heads from 0.01 up to 500.0 ml, depending on the site of administration, the type and age of the animal, and man - from 1.0 to 200.0 ml, depending on the site of administration and age. Milk product is administered to humans and animals for the correction of microflora: the gastrointestinal tract, uterus and vagina, oral, conjunctival and nasal cavities, wound cavities of various etiologies. The claimed methods provide an increase in the shelf life of the sour-milk product and the improvement of taste properties by reducing the acidity of the medium, which is in the range of 70-200 ° T; reducing the acidity of the environment also provides increased efficiency when using sour-milk product for the correction of microflora, because creates a favorable environment for lactobacilli.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KZ20061367 | 2006-12-05 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200700672A1 true EA200700672A1 (en) | 2008-06-30 |
| EA014227B1 EA014227B1 (en) | 2010-10-29 |
Family
ID=40863246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200700672A EA014227B1 (en) | 2006-12-05 | 2006-12-15 | A method for producing fermented milk product “maksilin” and a method for correcting microflora in an organism of a human and animals |
Country Status (1)
| Country | Link |
|---|---|
| EA (1) | EA014227B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITPD20090021A1 (en) * | 2009-02-03 | 2010-08-04 | Sitar S R L | MEDICAL AND / OR FOOD AND / OR FOOD AND / OR PROBIOTIC SUPPLEMENT AND / OR HOMEOPATHIC PRODUCT WITH LISATES AND / OR TINDALIZED OF PHYSIOLOGICAL, LYSATED AND / OR TINDALIZED BACTERIA OF PHYSIOLOGICAL, LYSATED AND / OR TINDALIZED MICROBIAL FISIOL |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2655856C1 (en) * | 2017-05-29 | 2018-05-29 | Федеральное государственное бюджетное научное учреждение "Северо-Кавказский научно-исследовательский институт животноводства" | Method of application of probiotic feed additives for pig fattening for meat |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0577904T3 (en) * | 1992-07-06 | 1997-10-27 | Nestle Sa | The lactic acid bacteria. |
| RU2176668C1 (en) * | 2001-01-04 | 2001-12-10 | Федеральное Государственное унитарное предприятие научно-производственное объединение "Вирион" | Strain of bacterium lactobacillus acidophilus nv ep 317/402 "narine" tnci used for preparing curative-prophylactic preparations for intestine microflora normalization |
| RU2305410C2 (en) * | 2005-03-14 | 2007-09-10 | Государственное образовательное учреждение высшего профессионального образования Воронежская государственная технологическая академия | Method for producing of sour milk drink |
-
2006
- 2006-12-15 EA EA200700672A patent/EA014227B1/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITPD20090021A1 (en) * | 2009-02-03 | 2010-08-04 | Sitar S R L | MEDICAL AND / OR FOOD AND / OR FOOD AND / OR PROBIOTIC SUPPLEMENT AND / OR HOMEOPATHIC PRODUCT WITH LISATES AND / OR TINDALIZED OF PHYSIOLOGICAL, LYSATED AND / OR TINDALIZED BACTERIA OF PHYSIOLOGICAL, LYSATED AND / OR TINDALIZED MICROBIAL FISIOL |
Also Published As
| Publication number | Publication date |
|---|---|
| EA014227B1 (en) | 2010-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI837785B (en) | Use of cultures containing Bifidobacterium breve | |
| Fusco et al. | Beta‐Defensin‐2 and Beta‐Defensin‐3 Reduce Intestinal Damage Caused by Salmonella typhimurium Modulating the Expression of Cytokines and Enhancing the Probiotic Activity of Enterococcus faecium | |
| CN102905712B (en) | Be used for the treatment of the probiotic composition of enteritis | |
| Deng et al. | Co-administration of Bacillus subtilis RJGP16 and Lactobacillus salivarius B1 strongly enhances the intestinal mucosal immunity of piglets | |
| Brüssow | Nutrition, population growth and disease: a short history of lactose | |
| US20190365832A1 (en) | Compositions and methods for treating inflammatory related diseases or conditions using pediococcus acidilactici probiotics | |
| RU2011114988A (en) | METHOD FOR USING THE BACILLUS SUBTILIS STRAIN FOR STRENGTHENING ANIMAL HEALTH | |
| CN103221420A (en) | Compositions and methods for the delivery of therapeutic peptides | |
| JP6817966B2 (en) | Bacteria engineered to treat diseases associated with hyperammonemia | |
| JP6505018B2 (en) | Novel lactic acid bacteria, innate immunity activator comprising novel lactic acid bacteria as active ingredient, and food and drink containing novel lactic acid bacteria | |
| CN109803666A (en) | Composition and its application method including probiotics | |
| ES2979098T3 (en) | Bifidobacteria for increasing lean body mass | |
| Leng | Unravelling methanogenesis in ruminants, horses and kangaroos: the links between gut anatomy, microbial biofilms and host immunity | |
| CN103764155A (en) | Lactic acid bacteria for promoting physical activity | |
| JP2011136907A (en) | Endurance-enhancing agent | |
| CN114262678B (en) | Lactobacillus fermentum Pm007 and application thereof | |
| EA200700672A1 (en) | METHOD OF OBTAINING THE ACID-MILK PRODUCT AND METHOD OF CORRECTING MICROFLORA IN THE ORGANISM | |
| US20230017155A1 (en) | Sleep improving agent | |
| WO2005089104A3 (en) | Feeds containing hop acids and uses thereof as supplements in animal feeds | |
| ES2358746T3 (en) | NEW CEPA THAT CONFERTS THERAPEUTIC PROPERTIES TO THE COMPOSITIONS OF BONE AND BACTERIAL CELLS. | |
| BR122022016606B1 (en) | LACTOBACILLUS PARACASEI DEAD BY HEATING, DRUG, FOOD OR DRINK, FEED, AGENT PROMOTING IL-12 PRODUCTION AND USE | |
| CN108495643A (en) | The composition and application method of novel fermentation lactobacillus strain | |
| WO2019188943A1 (en) | Composition for preventing and/or ameliorating decrease in brain blood flow | |
| Laomongkholchaisri et al. | Impact of potential probiotic Lactobacillus strains on host growth and development in a Drosophila melanogaster model | |
| JP7536504B2 (en) | Agent for improving depressive symptoms and composition containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |
|
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| PC4A | Registration of transfer of a eurasian patent by assignment | ||
| PC4A | Registration of transfer of a eurasian patent by assignment |